Benefits Realisation Management

Why delivery progress is not proof of value

Delivery health and value health answer different questions. This guide shows how to keep them connected without treating a green project status as proof that benefits are being realised.

Wovex

Illustration of two connected status panels: delivery milestones with a green status on the left, and a rising value-evidence line with a separate confidence indicator on the right.

Delivery progress can show that a team is doing the work: milestones are moving, money is being controlled, risks are being managed, and outputs are being produced. It does not, by itself, show that the intended outcomes and benefits are appearing.

A useful governance conversation therefore needs two connected views:

  • delivery health — whether the work is under control; and

  • value health — whether the expected change remains credible and is appearing in evidence.

Both matter. Neither should be used as a substitute for the other.

The familiar green-project problem

A project can be green because its schedule, cost, scope and risks are within tolerance. That is valuable information. It tells leaders something about the team’s ability to deliver what was planned.

The same status may say very little about whether people are using what has been delivered, whether behaviour or performance is changing, or whether the expected benefits remain achievable.

This is where project success and investment success can quietly separate. The project can complete its outputs successfully while the organisation still lacks evidence that the investment is changing anything that matters.

The answer is not to weaken delivery governance. It is to stop asking one status to answer two different questions.

Delivery health and value health answer different questions

View

Main question

Typical signals

What it cannot establish on its own

Delivery health

Is the work being delivered under control?

Milestones, cost, scope, resources, risks, dependencies and quality

Whether the intended outcomes and benefits are occurring

Value health

Does the expected value remain credible and visible in evidence?

Adoption, outcome measures, benefit measures, baselines, forecasts, actuals, variance and confidence

Whether delivery is well controlled or whether the observed change was caused by the initiative

A strong review connects these views. For example, a delayed deliverable may weaken a benefit forecast. Low adoption may reveal that an output is complete but not yet creating the expected outcome. A change in external conditions may reduce value even when delivery remains on plan.

The connection matters. The confusion does not help.

Why one overall status creates blind spots

When delivery and value are compressed into a single RAG status, several problems can follow.

First, the most frequently reported information tends to dominate. Delivery data is often available earlier and more frequently, so it serves as shorthand for the entire investment.

Second, different types of uncertainty disappear. A team may be highly confident about the delivery date but much less confident about adoption or the evidence behind a forecast benefit.

Third, the conversation can end too early. A green status reassures the room, but it may not prompt anyone to ask what has changed in the value case or what decision follows.

A better status model does not necessarily require more reporting. It requires clearer questions and a clear distinction between evidence of work and evidence of value.

Five questions for a combined delivery and value review

Use these questions together in the same governance conversation.

1. What has been delivered or changed?

Describe the relevant outputs, releases, process changes, capability changes or adoption activity. Be specific enough to show what the team has actually done.

2. What was expected to change as a result?

Restate the intended outcomes and benefits. Include who should experience the change, when it should become visible and any important assumptions or dependencies.

3. What does the current evidence show?

Compare actual evidence with the most relevant reference point:

  • the baseline, when asking what has changed;

  • the forecast, when asking whether the expected trajectory remains credible;

  • the target, when asking whether the desired level has been reached; or

  • an agreed tolerance, when deciding whether intervention is required.

Do not present a number without explaining what it is being compared with and why that comparison matters.

4. How confident are we in the value view?

Consider the freshness, completeness and relevance of the evidence. Identify important assumptions, gaps and alternative explanations. Confidence should be assessed, not added as a decorative label.

5. What decision or action follows?

A useful review should lead somewhere. The next step might be to continue, correct delivery, strengthen adoption, collect better evidence, revise a forecast, change scope, escalate a risk or record that no action is required.

Reporting is an input to governance. It is not the completion of governance.

Illustrative scenario: a platform delivered on time

This is an illustrative scenario, not a customer case study.

An organisation delivers a new service platform on time and within budget. The project has completed the planned releases, trained users and resolved its critical defects. Delivery health is green.

The value case expected the platform to reduce handling time, improve decision consistency, and make the service easier for customers to use.

Two months after launch, the evidence shows that only part of the workforce is using the new process consistently. Handling time has not yet improved, and customer feedback is mixed. The benefit forecast is now less certain than it was at the time of approval.

A weak review would either call the project successful because delivery is green or call it a failure because the benefits have not yet appeared.

A stronger review would separate the questions:

  • delivery has performed well;

  • adoption is below expectation;

  • the expected outcomes remain possible but are less certain;

  • the immediate decision is to strengthen adoption, investigate the mixed feedback and review the forecast at the next evidence point.

That conclusion is more useful because it preserves what is working, exposes what is not yet working and identifies the next decision.

Common failure modes and corrective actions

The benefits register is reviewed separately

Failure mode: Delivery data is discussed in the main governance meeting, while benefits information is maintained elsewhere and reviewed less often.

Correction: Bring the material value signals into the same decision rhythm. Keep detailed records where they belong, but make the relationship between delivery and value visible.

Measures exist without a usable reference point

Failure mode: A measure is reported, but the baseline, forecast, target or tolerance is missing or ambiguous.

Correction: State the reference point and the reason for the comparison. A value without context rarely supports a decision.

Project closure is treated as proof of success

Failure mode: Completion of outputs is reported as confirming that benefits have been realised.

Correction: Define the post-delivery ownership, evidence rhythm and review point before closure. Some benefits appear after the project team has moved on.

One RAG status hides different stories

Failure mode: A single status combines delivery control, benefit performance and confidence.

Correction: Keep delivery health, value health and confidence distinguishable. Connect them through explanation rather than averaging them into one colour.

The review produces information but no decision

Failure mode: Dashboards are updated and presented, but no action, decision or learning is recorded.

Correction: End with the required decision, the owner, and the next evidence point.

What this discipline can and cannot establish

Keeping delivery health and value health visible can improve review, ownership and decision-making. It can help leaders see when good delivery is not yet translating into value and when a value forecast needs attention, even when the work is on track.

It does not prove causality, guarantee benefits, replace business-case governance or remove the need for human judgement. It also does not imply that a temporary gap between delivery and value is automatically a failure. Some outcomes take time, and some forecasts legitimately change as evidence improves.

The purpose is simpler: make the two questions visible, keep them connected and use the evidence to decide what happens next.

A short review prompt

Before closing the next governance conversation, ask:

  1. What does the delivery view tell us?

  2. What does the value view tell us?

  3. Where do they reinforce or contradict each other?

  4. What uncertainty matters?

  5. What decision or action follows?

Delivery confidence is not value confidence. Strong governance makes both visible.

Explore more practical guidance in the Wovex Knowledge Base.